Recital 13, Regulation (EU) 2021/525

In forcesince 19 Oct 2020

An evaluation of the potential for unintended effects of substances on the immune system should be conducted. However, as no specific developmental immunotoxicity study is available in an OECD test guideline, relevant data should be required to be provided as additional data set.